Jean-Pierre Gaspard
Jean-Pierre Gaspard – AFM-Telethon

Jean-Pierre Gaspard is the Chief Operating Officer of the Biotherapies Institute (since 2013) and the Managing Director of the AFM-Telethon (since 2016).

In parallel, he is a member of the Board of Directors of I-Stem and Atlantic Gene Therapies and Vice-President of the CCTR (Centre for Clinical and Translational Research, CRCT in French).

Jean-Pierre Gaspard is a senior lecturer at HEC (a prestigious French business school) and co-founder of a “think-tank” that regularly gathers directors from large research or solidarity associations.



Géraldine Honnet – Genethon

Géraldine Honnet is Director of Clinical Development at Genethon. Previously, Geraldine Honnet was in charge of Clinical Development in Infectious Diseases at Transgene, International Project Manager at Janssen-Cilag and Medical Director at Parexel International. She also worked at the Saint-Louis Hospital as Clinical Trials Monitor and Investigator for the ANRS and the pharmaceutical industry, respectively.

Geraldine received her medical degree from Necker Enfants-Malade University Hospital (CHU).

Fulvio Mavilio Fulvio Mavilio – Genethon

Fulvio Mavillo was the Director of Exploratory Research at Molmed (2002-2005), founder and Scientific Director of Genera (1999-2002), and co-Director of The San Raffaele-Telethon Institute for Gene therapy, Milan, Italy (1995-2002). He is a member of the European Molecular Biology Organization (EMBO),

President of the Education Committee of the American Society of Gene Therapy (ASGT), Fulvio Mavillo is a member of the Editorial Board of many international journals in the fields of genetics, molecular biology and gene therapy.
In 1976 Fulvio Mavillo graduated from the University of Rome with a degree in Biology and obtained his Ph.D. in Medical Genetics from the Medical School of the same university in 1979. He taught as a visiting scientist at the Wistar Institute, Philadelphia, USA, from 1985 to 1989.

Expert and pioneer in the fields of gene therapy and stem cell research, Fulvio Mavillo has published over 140 articles in leading international journals. He is also Professor of Molecular Biology at the University of Modena and Reggio Emilia, Italy.


Marc Peschanksi Marc Peschanski – I-Stem

A medical doctor with a PhD in neuroscience, Marc Peschanski joined Inserm in 1982 where he began research working on the neurophysiology and anatomy of pain, in Paris and San Francisco.

Since 1985 he has devoted himself to study nervous system plasticity and neuron transplantation.

In 1991, he became director of the Inserm laboratory in Créteil (Henri-Mondor Hospital). At that time, his team performed the first transplantation of foetal neurons in France and the world’s first transplantation in patients with Huntington’s chorea. The results helped start a phase II European study in a hundred patients, currently in progress in 7 countries.

Marc Peschanski was one of the founders of the Clinical Investigation Centre at Henri-Mondor Hospital and Clinical Investigation Centre dedicated to biotherapies associated with it. He also initiated the Network for European CNS Transplantation and Restoration (NECTAR), of which he was the first president in 1991-92.


Marianne-Perreau-Saussine Marianne Perreau-Saussine – Institute of Myology 
A graduate from a business school, the Paris Institute of Political Science (Science Po Paris) and the University Paris Descartes (Masters degree-DEA, in medical ethics), Marianne Perreau-Saussine became hospital director in 1999. She has over 15 years experience in the hospital sector, at the local (CH Mantes-la-Jolie), regional (ARH Ile-de-France, ARS Ile-de-France) and national level (National Cancer Institute, Interministerial Mission for the Fight against Cancer). She has thus driven significant hospital reorganisations, development of public health programs and implementation of structures in the area of healthcare organisation and research. By joining the Institute of Myology, she wished to join the world of research and the development of innovations, and to engage with families to overcome diseases.
The General Secretary is assisted by a coordinating team of about ten people who manage computer, documentation, accounting, HR, audiovisual and logistic questions.